Please provide your email address to receive an email when new articles are posted on . Qdata Geographic Atrophy will improve understanding of practice patterns, decision-making and outcomes. The ...

Geographic atrophy is a leading cause of blindness. The new approval will help to fill an unmet need for patients. The first ever treatment for geographic atrophy (GA) was approved by the FDA.

Geographic atrophy (GA) is a chronic, progressive degeneration of the macula that can occur in some people with dry macular degeneration. GA is a late, or advanced, stage of the disease. The people ...

What is IZERVAY™?IZERVAY (avacincaptad pegol intravitreal solution) is a prescription eye injection, used to treat geographic atrophy (GA), the advanced form of dry age-related macular degeneration ...

This eye condition is a late-stage form of age-related macular degeneration, which is a leading cause of blindness in Americans 65 or older. If you or a loved one has been diagnosed with GA, it can ...